SEARCH

SEARCH BY CITATION

References

  • Antoine, G., Zimmermann, K., Plaimauer, B., Grillowitzer, M., Studt, J.D., Lämmle, B. & Scheiflinger, F. (2003) ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13. British Journal of Haematology, 120, 821824.
  • Assink, K., Schiphorst, R., Allford, S., Karpman, D., Etzioni, A., Brichard, B., van de Kar, N., Monnens, L. & van den Heuvel, L. (2003) Mutation analysis and clinical implications of von Willebrand factor-cleaving protease deficiency. Kidney International, 63, 19951999.
  • Banno, F., Kaminaka, K., Soejima, K., Kokame, K. & Miyata, T. (2004) Identification of strain-specific variants of mouse Adamts13 gene encoding von Willebrand factor-cleaving protease. Journal of Biological Chemistry, 279, 3089630903.
  • Böhm, M., Vigh, T. & Scharrer, I. (2002) Evaluation and clinical application of a new method for measuring activity of von Willebrand factor-cleaving metalloprotease (ADAMTS13). Annals of Hematology, 81, 430435.
  • Dent, J.A., Berkowitz, S.D., Ware, J., Kasper, C.K. & Ruggeri, Z.M. (1990) Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. Proceedings of the National Academy of Sciences of the United States of America, 87, 63066310.
  • Furlan, M. & Lämmle, B. (2002) Assays of von Willebrand factor-cleaving protease: a test for diagnosis of familial and acquired thrombotic thrombocytopenic purpura. Seminars in Thrombosis and Hemostasis, 28, 167172.
  • Furlan, M., Robles, R. & Lämmle, B. (1996) Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood, 87, 42234234.
  • Furlan, M., Robles, R., Galbusera, M., Remuzzi, G., Kyrle, P.A., Brenner, B., Krause, M., Scharrer, I., Aumann, V., Mittler, U., Solenthaler, M. & Lämmle, B. (1998) von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. New England Journal of Medicine, 339, 15781584.
  • George, J.N. & Vesely, S.K. (2004) ADAMTS13 and TTP: the clot thickens. Blood, 103, 39973998.
  • Gerritsen, H.E., Turecek, P.L., Schwarz, H.P., Lämmle, B. & Furlan, M. (1999) Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Thrombosis and Haemostasis, 82, 13861389.
  • Jenkins, P.V., Pasi, K.J. & Perkins, S.J. (1998) Molecular modeling of ligand and mutation sites of the type A domains of human von Willebrand factor and their relevance to von Willebrand's disease. Blood, 91, 20322044.
  • Kokame, K., Matsumoto, M., Soejima, K., Yagi, H., Ishizashi, H., Funato, M., Tamai, H., Konno, M., Kamide, K., Kawano, Y., Miyata, T. & Fujimura, Y. (2002) Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity. Proceedings of the National Academy of Sciences of the United States of America, 99, 1190211907.
  • Kokame, K., Matsumoto, M., Fujimura, Y. & Miyata, T. (2004) VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13. Blood, 103, 607612.
  • Levy, G.G., Nichols, W.C., Lian, E.C., Foroud, T., McClintick, J.N., McGee, B.M., Yang, A.Y., Siemieniak, D.R., Stark, K.R., Gruppo, R., Sarode, R., Shurin, S.B., Chandrasekaran, V., Stabler, S.P., Sabio, H., Bouhassira, E.E., Upshaw, J.D. Jr, Ginsburg, D. & Tsai, H.M. (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature, 413, 488494.
  • Mannami, T., Konishi, M., Baba, S., Nishi, N. & Terao, A. (1997) Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita study. Stroke, 28, 518525.
  • Mannucci, P.M., Canciani, M.T., Forza, I., Lussana, F., Lattuada, A. & Rossi, E. (2001) Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood, 98, 27302735.
  • Matsumoto, M., Kokame, K., Soejima, K., Miura, M., Hayashi, S., Fujii, Y., Iwai, A., Ito, E., Tsuji, Y., Takeda-Shitaka, M., Iwadate, M., Umeyama, H., Yagi, H., Ishizashi, H., Banno, F., Nakagaki, T., Miyata, T. & Fujimura, Y. (2004) Molecular characterization of ADAMTS13 gene mutations in Japanese patients with Upshaw-Schulman syndrome. Blood, 103, 13051310.
  • Moake, J.L., Rudy, C.K., Troll, J.H., Weinstein, M.J., Colannino, N.M., Azocar, J., Seder, R.H., Hong, S.L. & Deykin, D. (1982) Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. New England Journal of Medicine, 307, 14321435.
  • Moschcowitz, E. (1924) Hyaline thrombosis of the terminal arterioles and capillaries; a hitherto undescribed disease. Proceedings of the New York Pathological Society, 24, 2124.
  • Nishio, K., Anderson, P.J., Zheng, X.L. & Sadler, J.E. (2004) Binding of platelet glycoprotein Ibα to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13. Proceedings of the National Academy of Sciences of the United States of America, 101, 1057810583.
  • Obert, B., Tout, H., Veyradier, A., Fressinaud, E., Meyer, D. & Girma, J.P. (1999) Estimation of the von Willebrand factor-cleaving protease in plasma using monoclonal antibodies to VWF. Thrombosis and Haemostasis, 82, 13821385.
  • Pimanda, J.E., Maekawa, A., Wind, T., Paxton, J., Chesterman, C.N. & Hogg, P.J. (2004) Congenital thrombotic thrombocytopenic purpura in association with a mutation in the second CUB domain of ADAMTS13. Blood, 103, 627629.
  • Plaimauer, B., Zimmermann, K., Volkel, D., Antoine, G., Kerschbaumer, R., Jenab, P., Furlan, M., Gerritsen, H., Lämmle, B., Schwarz, H.P. & Scheiflinger, F. (2002) Cloning, expression and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13). Blood, 100, 36263632.
  • Savasan, S., Lee, S.K., Ginsburg, D. & Tsai, H.M. (2003) ADAMTS13 gene mutation in congenital thrombotic thrombocytopenic purpura with previously reported normal VWF cleaving protease activity. Blood, 101, 44494451.
  • Schneppenheim, R., Budde, U., Oyen, F., Angerhaus, D., Aumann, V., Drewke, E., Hassenpflug, W., Haberle, J., Kentouche, K., Kohne, E., Kurnik, K., Mueller-Wiefel, D., Obser, T., Santer, R. & Sykora, K.W. (2003) von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP. Blood, 101, 18451850.
  • Soejima, K., Mimura, N., Hirashima, M., Maeda, H., Hamamoto, T., Nakagaki, T. & Nozaki, C. (2001) A novel human metalloprotease synthesized in the liver and secreted into the blood: possibly, the von Willebrand factor-cleaving protease? Journal of Biochemistry, 130, 475480.
  • Studt, J.D., Böhm, M., Budde, U., Girma, J.P., Varadi, K. & Lämmle, B. (2003) Measurement of von Willebrand factor-cleaving protease (ADAMTS-13) activity in plasma: a multicenter comparison of different assay methods. Journal of Thrombosis and Haemostasis, 1, 18821887.
  • Sutherland, J.J., O'Brien, L.A., Lillicrap, D. & Weaver, D.F. (2004) Molecular modeling of the von Willebrand factor A2 domain and the effects of associated type 2A von Willebrand disease mutations. Journal of Molecular Modeling (Online), 10, 259270.
  • Tripodi, A., Chantarangkul, V., Böhm, M., Budde, U., Dong, J.F., Friedman, K.D., Galbusera, M., Girma, J.P., Moake, J., Rick, M.E., Studt, J.D., Turecek, P.L. & Mannucci, P.M. (2004) Measurement of von Willebrand factor cleaving protease (ADAMTS-13): results of an international collaborative study involving 11 methods testing the same set of coded plasmas. Journal of Thrombosis and Haemostasis, 2, 16011609.
  • Tsai, H.M. (1996) Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood, 87, 42354244.
  • Tsai, H.M. & Lian, E.C. (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. New England Journal of Medicine, 339, 15851594.
  • Tsai, H.M., Sussman, I.I. & Nagel, R.L. (1994) Shear stress enhances the proteolysis of von Willebrand factor in normal plasma. Blood, 83, 21712179.
  • Vesely, S.K., George, J.N., Lämmle, B., Studt, J.D., Alberio, L., El-Harake, M.A. & Raskob, G.E. (2003) ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood, 102, 6068.
  • Veyradier, A., Obert, B., Houllier, A., Meyer, D. & Girma, J.P. (2001) Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases. Blood, 98, 17651772.
  • Zheng, X., Chung, D., Takayama, T.K., Majerus, E.M., Sadler, J.E. & Fujikawa, K. (2001) Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. Journal of Biological Chemistry, 276, 4105941063.
  • Zheng, X.L., Kaufman, R.M., Goodnough, L.T. & Sadler, J.E. (2004) Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura. Blood, 103, 40434049.